Home

Senior Care

Study Results Fuel Avandia Safety Controversy

Mon, 23 Nov 2009 GMT

NEWS YOU CAN TRUST

Browser Preferences
Add to Favorites

Main Menu

Home

- - - - - Hot Topics - - - - -

Bird Flu

Drug Safety

Stem Cell Research

- - - - - - - - - - - - - - - - -

*Diseases & Conditions

Pain

Parenting

Public Health & Safety

Senior Care

*Sexual Health

Women's Health

World Health

- - - - - - - - - - - - - - - -

Web Links

XML News Feeds

HEALTH NEWS

Study Results Fuel Avandia Safety Controversy

12 December, 2007 04:19 GMT

New research is sparking renewed debate over the safety of the diabetes prescription drug Avandia. In a study of 160,000 patients over the age of 65, those who took Avandia to treat their type 2 diabetes were found to be significantly more susceptible to congestive heart failure, heart attacks and death than those who took other diabetes pills.

Avandia May Cut Diabetes Risk in Half (15 Sep 2006)

FDA Panel Votes to Keep Avandia on Market Despite Risks (31 Jul 2007)

Actos, Avandia or Neither? The Diabetes Drug Debate (Video) (14 Oct 2007)

FDA Oks Merck's Januvia for Type 2 Diabetes (18 Oct 2006)

Smoking Linked to Higher Diabetes Risk (26 Sep 2005)

Type 2 Diabetics Fooling Themselves About Blood-Sugar Control (18 May 2005)